4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-22-036877
Options or other derivatives
- Chief Financial Officer acquired 256,438 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
O'Loughlin Steve · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-07-01 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +256,438 | 256,348 | D |
Loading xslF345X03/ownership.xml…